Effects of antibiotic therapy on the gastrointestinal microbiota and the influence ofLactobacillus casei
Open Access
- 1 September 2013
- journal article
- research article
- Published by Informa UK Limited in Food and Agricultural Immunology
- Vol. 24 (3), 315-330
- https://doi.org/10.1080/09540105.2012.689816
Abstract
Effects of intervention with Lactobacillus casei Shirota (LcS) on the incidence of antibiotic-associated diarrhoea (AAD), Clostridium difficile infection (CDI) and changes in faecal microbiota were analysed using C. difficile ELISA (678 patients), qPCR using 16S rRNA group-specific primers, C. difficile-toxin kit and polymerase chain reaction/denaturing gradient gel electrophoresis (56 patients). As much as 18.5% of antibiotic treated group developed AAD, but only 5% of patients treated with antibiotics and LcS. Following antibiotic therapy, a decrease in the abundance of total Bacteria, Clostridium cluster IV and XI, Bifidobacterium spp. and butyryl-CoA CoA transferase genes was observed, whereas Enterobacteriaceae increased. LcS intervention reduced the antibiotic-associated decrease in the diversity of microbiota, increased the abundance of Lactobacillus spp. and reduced the antibiotic-induced decrease of Bifidobacterium spp. Antibiotic treatment affects the diversity and the composition of the microbiota impairing butyrate production. Intervention with certain Lactobacillus strains may antagonise some of these changes, and more potent short-chain fatty acid-stimulating probiotics are desirable for intervention in AAD.Keywords
This publication has 51 references indexed in Scilit:
- Enterotypes of the human gut microbiomeNature, 2011
- Potential beneficial effects of butyrate in intestinal and extraintestinal diseasesWorld Journal of Gastroenterology, 2011
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbationProceedings of the National Academy of Sciences, 2010
- Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C . difficile tcdB , and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture MethodsJournal of Clinical Microbiology, 2009
- Comparison of Three Commercial Methods for Rapid Detection of Clostridium difficile Toxins A and B from Fecal SpecimensJournal of Clinical Microbiology, 2008
- Assembly of the human intestinal microbiotaTrends in Ecology & Evolution, 2006
- Resilience of the Dominant Human Fecal Microbiota upon Short-Course Antibiotic ChallengeJournal of Clinical Microbiology, 2005
- Diversity of the Human Intestinal Microbial FloraScience, 2005
- Host-Bacterial Mutualism in the Human IntestineScience, 2005
- Application of the Colon-Simulation Technique for Studying the Effects of Saccharomyces boulardii on Basic Parameters of Porcine Cecal Microbial Metabolism Disturbed by ClindamycinDigestion, 2000